Pendal Group LTD Merck & Co., Inc. Transaction History

Pendal Group LTD

$12.2 Billion
Q4 2022

A detailed history of Pendal Group LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pendal Group LTD holds 258,263 shares of MRK stock, worth $25.5 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

258,263

Previous 216,992 19.02%

Holding current value

$25.5 Million

Previous $18.7 Million 53.31%

% of portfolio

0.23%

Previous 0.18%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	BUY	$87.44 - $112.11 $3.61 Million - $4.63 Million	41,271 Added 19.02%	258,263 $0
Q3 2022 Oct 18, 2022	SELL	$84.53 - $94.96 $4.52 Million - $5.08 Million	-53,524 Reduced 19.79%	216,992 $18.7 Million
Q2 2022 Jul 25, 2022	BUY	$83.49 - $94.64 $379,295 - $429,949	4,543 Added 1.71%	270,516 $24.7 Million
Q1 2022 Apr 25, 2022	BUY	$73.51 - $82.4 $4.92 Million - $5.52 Million	66,982 Added 33.66%	265,973 $21.8 Million
Q4 2021 Jan 18, 2022	BUY	$72.28 - $90.54 $2.76 Million - $3.45 Million	38,130 Added 23.7%	198,991 $15.3 Million
Q3 2021 Nov 05, 2021	SELL	$71.68 - $78.83 $2.92 Million - $3.21 Million	-40,769 Reduced 20.22%	160,861 $12.1 Million
Q2 2021 Jul 28, 2021	BUY	$70.31 - $77.77 $144,627 - $159,972	2,057 Added 1.03%	201,630 $15.7 Million
Q1 2021 May 24, 2021	BUY	$68.86 - $81.11 $13.7 Million - $16.2 Million	199,573 New	199,573 $15.4 Million
Q1 2021 May 03, 2021	SELL	$68.86 - $81.11 $14.3 Million - $16.9 Million	-208,178 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$71.77 - $79.65 $23,899 - $26,523	-333 Reduced 0.16%	208,178 $17 Million
Q3 2020 Nov 02, 2020	SELL	$73.18 - $82.95 $4.74 Million - $5.38 Million	-64,840 Reduced 23.72%	208,511 $17.3 Million
Q2 2020 Aug 07, 2020	BUY	$70.42 - $80.13 $2.12 Million - $2.42 Million	30,170 Added 12.41%	273,351 $21.1 Million
Q1 2020 May 04, 2020	BUY	$63.36 - $87.82 $3.16 Million - $4.37 Million	49,799 Added 25.75%	243,181 $17.9 Million
Q4 2019 Feb 06, 2020	SELL	$77.58 - $87.54 $4.27 Million - $4.81 Million	-54,987 Reduced 22.14%	193,382 $16.8 Million
Q3 2019 Nov 12, 2019	SELL	$76.08 - $82.93 $10.2 Million - $11.1 Million	-133,537 Reduced 34.97%	248,369 $19.9 Million
Q2 2019 Aug 01, 2019	SELL	$69.84 - $81.59 $9.55 Million - $11.2 Million	-136,703 Reduced 26.36%	381,906 $0
Q1 2019 May 01, 2019	BUY	$69.58 - $79.36 $160,868 - $183,480	2,312 Added 0.45%	518,609 $0
Q4 2018 Jan 30, 2019	BUY	$65.24 - $75.71 $8.2 Million - $9.51 Million	125,660 Added 32.17%	516,297 $37.6 Million
Q3 2018 Nov 05, 2018	SELL	$57.69 - $67.84 $3.39 Million - $3.99 Million	-58,781 Reduced 13.08%	390,637 $0
Q2 2018 Jul 18, 2018	SELL	$50.83 - $59.72 $460,824 - $541,421	-9,066 Reduced 1.98%	449,418 $0
Q1 2018 May 08, 2018	BUY	$50.96 - $59.23 $407,883 - $474,076	8,004 Added 1.78%	458,484 $0
Q4 2017 Feb 06, 2018	BUY	$51.62 - $61.64 $1.73 Million - $2.06 Million	33,461 Added 8.02%	450,480 $0
Q3 2017 Nov 01, 2017	BUY	$58.67 - $63.13 $919,710 - $989,625	15,676 Added 3.91%	417,019 $0
Q2 2017 Aug 11, 2017	BUY	N/A	401,343	401,343 $0

Others Institutions Holding MRK

# of Institutions

3,819

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $250B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Account